Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study - Related Studies

Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study (CAN-003X)

This study is ongoing, but not recruiting participants.

Study NCT01617629 Information provided by Prima BioMed Ltd

First Received on June 8, 2012. Last Updated on January 14, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Sponsors listed in this trial

Prima BioMed Ltd